Invesco Pharmaceuticals ETF (NYSEARCA:PJP) Short Interest Update

Invesco Pharmaceuticals ETF (NYSEARCA:PJP) was the recipient of a significant increase in short interest in the month of June. As of June 15th, there was short interest totaling 16,116 shares, an increase of 2,312.6% from the May 31st total of 668 shares. Approximately 0.5% of the shares of the stock are short sold. Based on an average daily volume of 18,819 shares, the short-interest ratio is presently 0.9 days.

Invesco Pharmaceuticals ETF Trading Up 0.7%

PJP stock traded up $0.78 during trading on Thursday, hitting $115.68. The company had a trading volume of 4,781 shares, compared to its average volume of 33,049. The company has a market cap of $378.27 million, a P/E ratio of 15.59 and a beta of 0.46. The company has a fifty day moving average price of $108.51 and a two-hundred day moving average price of $106.63. Invesco Pharmaceuticals ETF has a fifty-two week low of $79.47 and a fifty-two week high of $117.09.

Hedge Funds Weigh In On Invesco Pharmaceuticals ETF

Several institutional investors have recently bought and sold shares of PJP. Jones Financial Companies Lllp raised its holdings in shares of Invesco Pharmaceuticals ETF by 11.6% in the first quarter. Jones Financial Companies Lllp now owns 2,428 shares of the company’s stock valued at $210,000 after buying an additional 252 shares during the last quarter. BNP Paribas Financial Markets bought a new position in Invesco Pharmaceuticals ETF during the second quarter worth about $799,000. Tower Research Capital LLC TRC boosted its stake in Invesco Pharmaceuticals ETF by 102.9% during the 2nd quarter. Tower Research Capital LLC TRC now owns 4,680 shares of the company’s stock worth $374,000 after acquiring an additional 2,374 shares during the last quarter. Ameriprise Financial Inc. grew its holdings in shares of Invesco Pharmaceuticals ETF by 214.4% in the 3rd quarter. Ameriprise Financial Inc. now owns 12,236 shares of the company’s stock valued at $1,114,000 after buying an additional 8,344 shares during the period. Finally, Citadel Advisors LLC acquired a new position in Invesco Pharmaceuticals ETF in the third quarter valued at about $504,000.

About Invesco Pharmaceuticals ETF

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.